1 Introduction 9
1.1 Industry Definition and Research Scope 9
1.1.1 Industry Definition 9
1.1.2 Research Scope 10
1.2 Research Methodology 13
1.2.1 Overview of Market Research Methodology 13
1.2.2 Market Assumption 14
1.2.3 Secondary Data 14
1.2.4 Primary Data 14
1.2.5 Data Filtration and Model Design 15
1.2.6 Market Size/Share Estimation 16
1.2.7 Research Limitations 17
1.3 Executive Summary 18
2 Market Overview and Dynamics 21
2.1 Market Size and Forecast 21
2.1.1 Impact of COVID-19 on World Economy 22
2.1.2 Impact of COVID-19 on the Market 24
2.2 Major Growth Drivers 31
2.3 Market Restraints and Challenges 39
2.4 Emerging Opportunities and Market Trends 42
2.5 Porters Fiver Forces Analysis 46
3 Segmentation of Asia Pacific Market by Synthesis 50
3.1 Market Overview by Synthesis 50
3.2 Synthetic API 52
3.2.1 Branded Synthetic API 53
3.2.2 Generic Synthetic API 54
3.3 Biotech API 55
3.3.1 Biotech API by Drug Type 56
3.3.1.1 Monoclonal Antibodies 57
3.3.1.2 Recombinant Proteins 58
3.3.1.3 Vaccines 59
3.3.1.4 Other Biotech APIs 60
3.3.2 Biotech API by Category 61
3.3.2.1 Innovative Biologic API 62
3.3.2.2 Generic Biosimilar API 63
3.3.3 Biotech API by Expression Technology 64
3.3.3.1 Mammalian Expression 65
3.3.3.2 Microbial Expression 66
3.3.3.3 Yeast Expression 67
3.3.3.4 Insect Expression 68
3.3.3.5 Other Expression Technologies 69
3.4 HPAPI 70
3.4.1 Branded HPAPI 71
3.4.2 Generic HPAPI 72
4 Segmentation of Asia Pacific Market by Manufacturing Process 73
4.1 Market Overview by Manufacturing Process 73
4.2 Captive Manufacturing 75
4.2.1 Branded Captive API 76
4.2.2 Generic Captive API 77
4.3 Merchant Manufacturing 78
4.3.1 Merchant Manufacturing by Drug Type 79
4.3.1.1 Branded Merchant API 80
4.3.1.2 Generic Merchant API 81
4.3.2 Merchant Manufacturing by Drug Synthesis 82
4.3.2.1 Merchant Synthetic API 83
4.3.2.2 Merchant Biotech API 84
5 Segmentation of Asia Pacific Market by Therapeutic Application 85
5.1 Market Overview by Therapeutic Application 85
5.2 Infectious Diseases 87
5.3 Oncology 88
5.4 Ophthalmology 89
5.5 Cardiovascular Disorders 90
5.6 Central Nervous System 91
5.7 Pulmonary Disorders 92
5.8 Orthopedics 93
5.9 Other Applications 94
6 Segmentation of Asia Pacific Market by Drug Type 95
6.1 Market Overview by Drug Type 95
6.2 Branded Prescription Drugs 97
6.3 Generic Prescription Drugs 98
6.4 OTC Drugs 99
7 Asia-Pacific Market 2021-2028 by Country 100
7.1 Overview of Asia-Pacific Market 100
7.2 China 103
7.3 Japan 105
7.4 India 108
7.5 Australia 110
7.6 South Korea 112
7.7 Rest of APAC Region 114
8 Competitive Landscape 116
8.1 Overview of Key Vendors 116
8.2 New Product Launch, Partnership, Investment, and M&A 119
8.3 Company Profiles 120
AbbVie Inc. 120
Astrazeneca 122
Aurobindo Pharma Ltd. 127
BASF 130
Bayer AG 133
Boehringer Ingelheim 137
Catalent Inc. 142
Dr. Reddy's Laboratories 145
F. Hoffmann-La Roche 147
GlaxoSmithKline plc 149
Lonza Group 154
Lupin Limited 159
Merck & Co., Inc. 162
Mylan NV 165
Novartis International AG 168
Pfizer Inc. 171
Sanofi 176
Sun Pharmaceutical Industries Ltd. 179
Teva Pharmaceutical Industries Ltd. 182
Thermo Fisher Scientific 184
9 Investing in Asia Pacific Market: Risk Assessment and Management 186
9.1 Risk Evaluation of Asia Pacific Market 186
9.2 Critical Success Factors (CSFs) 189
Related Reports and Products 192